Nanoparticles for cancer therapy: current progress and challenges

S Gavas, S Quazi, TM Karpiński - Nanoscale research letters, 2021 - Springer
Cancer is one of the leading causes of death and morbidity with a complex pathophysiology.
Traditional cancer therapies include chemotherapy, radiation therapy, targeted therapy, and …

Nanoparticle-based drug delivery in cancer therapy and its role in overcoming drug resistance

Y Yao, Y Zhou, L Liu, Y Xu, Q Chen, Y Wang… - Frontiers in molecular …, 2020 - frontiersin.org
Nanotechnology has been extensively studied and exploited for cancer treatment as
nanoparticles can play a significant role as a drug delivery system. Compared to …

Polymeric nanoparticles for drug delivery: Recent developments and future prospects

B Begines, T Ortiz, M Pérez-Aranda, G Martínez… - Nanomaterials, 2020 - mdpi.com
The complexity of some diseases—as well as the inherent toxicity of certain drugs—has led
to an increasing interest in the development and optimization of drug-delivery systems …

[HTML][HTML] Recent progress in nanomedicine for enhanced cancer chemotherapy

G Wei, Y Wang, G Yang, Y Wang, R Ju - Theranostics, 2021 - ncbi.nlm.nih.gov
As one of the most important cancer treatment strategies, conventional chemotherapy has
substantial side effects and leads easily to cancer treatment failure. Therefore, exploring and …

Structure‐based varieties of polymeric nanocarriers and influences of their physicochemical properties on drug delivery profiles

R De, MK Mahata, KT Kim - Advanced Science, 2022 - Wiley Online Library
Carriers are equally important as drugs. They can substantially improve bioavailability of
cargos and safeguard healthy cells from toxic effects of certain therapeutics. Recently …

Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies

E Calzoni, A Cesaretti, A Polchi, A Di Michele… - Journal of functional …, 2019 - mdpi.com
Polymer nanoparticles (NPs) represent one of the most innovative non-invasive approaches
for drug delivery applications. NPs main objective is to convey the therapeutic molecule be …

P-glycoprotein inhibition for optimal drug delivery

ML Amin - Drug target insights, 2013 - journals.sagepub.com
P-glycoprotein (P-gp), an efflux membrane transporter, is widely distributed throughout the
body and is responsible for limiting cellular uptake and the distribution of xenobiotics and …

Nanomedicine of synergistic drug combinations for cancer therapy–Strategies and perspectives

RX Zhang, HL Wong, HY Xue, JY Eoh… - Journal of Controlled …, 2016 - Elsevier
Nanomedicine of synergistic drug combinations has shown increasing significance in
cancer therapy due to its promise in providing superior therapeutic benefits to the current …

Nanoparticle-based combination therapy toward overcoming drug resistance in cancer

CMJ Hu, L Zhang - Biochemical pharmacology, 2012 - Elsevier
The use of multiple therapeutic agents in combination has become the primary strategy to
treat drug resistant cancers. However, administration of combinatorial regimens is limited by …

[HTML][HTML] Current challenges of cancer anti-angiogenic therapy and the promise of nanotherapeutics

AME Abdalla, L Xiao, MW Ullah, M Yu, C Ouyang… - Theranostics, 2018 - ncbi.nlm.nih.gov
With growing interest in cancer therapeutics, anti-angiogenic therapy has received
considerable attention and is widely administered in several types of human cancers …